We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Judges Scientific Plc | JDG | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 10,900.00 | 08:00:10 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 10,900.00 | 10,900.00 | 10,900.00 | 10,900.00 |
| Industry Sector |
|---|
| ELECTRONIC & ELECTRICAL EQUIPMENT |
| Top Posts |
|---|
Posted at 16/2/2024 18:10 by davidosh NK104...you stated...I worked out today that with dividends I've made a profit of £9,900 in total down the years. And that's all thanks to the original posters like davidosh who alerted me to JDG. Think I might buy some for my Isa! It is certainly a pleasure to know others have gained measurably from investing in JDG and the benefit of David Cicurel coming to Mello over the past 15 years. DC always insisted on returning to our monthly Mello dinners when the results came out and he still features regularly in our virtual shows. I will try to get him to join us on our Results show on the 21st March. We will have at least six companies on that one. Did you attend one of the Beckenham dinners? Any Mello investors who bought at £1.78 when David Cicurel first came to Beckenham and held on tight with reinvested dividends would now have well over 100x their original investment |
Posted at 12/2/2024 09:16 by tomps2 Judges Scientific (JDG) FY23 results webinarThursday, 21 March, 4:45pm David Cicurel, Chief Executive Officer, Brad Ormsby, Chief Financial Officer, Mark Lavelle, Chief Operating Officer and Tim Prestidge, Group Business Development Director will host an online investor presentation covering the financial year ended 31 December 2023, followed by Q&A. Register here: bit.ly/JDG_FY23_resu |
Posted at 14/7/2023 14:33 by philanderer 'Weak economic outlook and downbeat investor sentiment equals acquisition opportunities'Questor share tip: Judge for yourself but it’s not rocket science that this is a fine time for mergers and purchases |
Posted at 24/3/2023 13:49 by melloteam Just to let shareholders and prospective investors know that David Cicurel (Judges Scientific) will be presenting on the MelloMonday webinar at 5pm on Monday the 27th of March. The programme for the evening is as follows: 5.00 pm Interview with Georgina Brittain, portfolio manager of JPMorgan UK Smaller Companies 5.30 pm Company presentation by Vector Capital plc 6.10 pm Company presentation by Fintel plc 6.40 pm Special guest interview David Cicurel 7.00 pm Company presentation by CentralNic Group plc 7.30 pm Mark Bentley introduces ShareSoc’s ‘Bank failures and their broader implications’ in-conversation event 7.35 pm Mello BASH with Damian Cannon, Kevin Taylor and Mark Simpson There will be over 500 investors attending and these are very popular shows with company presentations, fund manager and investor interviews, and panel sessions. Tickets are still available and if you would like one at half price then enter the code MMLINK50. |
Posted at 29/9/2022 12:40 by melloteam FREE RESULTS ROUND UPJust to let shareholders and prospective investors know that JDG will be discussed in the Results Round Up at the Results Round Up Webinar at 2pm - 6.30pm on Thursday 29th September 2022. . The programme is as follows: 2.00 pm David Stevenson discusses The Small Cap Discount : Opportunity Knocks with David Stredder 2.30 pm Company presentation by Fintel 3.00 pm Results Round-up from Graham Neary 3.30 pm Company presentation by Brave Bison 4.00 pm Company presentation by Avation 4.40 pm Company presentation by TPFG 5.00 pm Results Round-up from Mark Simpson including the Good, the Bad and the Ugly 5.30 pm Company presentation by S&U The event is FREE and there will be over 500 investors attending and these are very popular shows with company presentations, fund manager and investor interviews, and panel sessions. |
Posted at 21/2/2022 17:52 by km18 ...from last year...Company overview: Judges Scientific is a group specialised in the acquisition and development of scientific instrument companies. The 19 firms currently under the umbrella are primarily UK-based with clients across the world. The acquisition strategy is a classic where they look for international portfolio of clients and sustainable sales and profits, nothing outstanding there. It seems to be working well for them as the goodwill figure is nicely kept at just above 20% of total assets, taking into consideration the fact that they have acquisitions every year in the past decade. On top of that, fundamentals are strong, with revenues growing at CAGR 7.28% and net profits are seeing 60% CAGR, which is impressive. Returns for investors are healthy, with ROCE standing at 17% for 2020 and rising at 15% CAGR and dividends continuously rising over the past 10 years, reaching 15.5p in 2020. There are some pension deficits that need further analysis, as they boost the gearing to 33.7%. Cash generation is strong with CFO rising in 6 of the last 10 years. The interim results released today look promising. Revenue is bumped by 14.7% to £43m and PBT is 55.4% ahead of 2020 interim at £6.7m. Net debt (adjusted for the IFRS 16) is significantly improved from £5.7m to £1.7m. The underlying theme is also very positive with organic intake increasing 25% and even surpassing by 3% the record H1 2019. The company also secured £60m 5y bank facility to support acquisitions in the coming periods. Management expects the full year results to “exceed existing market expectations”. Short analysis: Cash cash has increase from December by 13.5%, due to strong CFO and a small issue of share capital Net debt decreased significantly to £1.7m CA/CL = 1.92 Cash ratio = 0.72 Interest coverage = 25.66 P/S TTM = 5.54, higher than the industry average BV ps = 605p, rising from 511p Operating profit is £7.1m, compared to £4.6m in H1 2020... .... from WealthOracleAM |
Posted at 11/10/2021 15:57 by davidosh We've had over 300 companies present at Mello in the last 15 yrs but none as successful to date as Judges Scientific which has 50 bagged for investors since David Cicurel came to dinner in 2009Tonight I interview him & discover the secret of his success |
Posted at 24/3/2021 14:32 by melloteam Just to let shareholders and prospective investors know that Judges Scientific plc will be presenting at Mello Events’ Results Roadshow Special webinar event on Monday 29th March at 5pm-9:30pm. There will also be other fantastic company presentations from GetBusy, Filta Group and Digitalbox plc.There will be over 600 investors attending and these are very popular shows with company presentations, fund manager and investor interviews, and panel sessions including the popular Mello BASH (Buy, Avoid, Sell or Hold). Tickets are still available and if you would like one at half price then enter the code MMTADVFN50. |
Posted at 16/12/2020 15:35 by cornishman33 Another all time high, but they seem to be too boring for most investors. For the patient these were selling for little more than £1 a decade ago, and have paid ever increasing dividends every year. Long may they continue to bore! |
Posted at 18/11/2019 16:52 by davidosh A great landmark reached today. Well done David Cicurel and the whole team plus all the subsids.David and JDG first came to our Mello dinner to present and meet investors in 2009 and has been back at least once every year since so tens and tens of Mello investors came on board as shareholders. The price was £1.78 at the first Mello from memory so that is almost 30x and certainly is with dividends included and he always requests to come back and update everyone each year. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
